INS and metabolic dysfunction-associated steatotic liver disease: Thus, our findings together with the observation of increased hepatic Pparγ2 expression in obese models and NAFLD provide evidence that insulin is sufficient to induce, but is not required for maintenance of, Pparγ2 expression.